NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 64 filers reported holding NEOS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 3.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,769,000 | -72.8% | 364,697 | -65.0% | 1.10% | -52.4% |
| Q2 2018 | $6,504,000 | -46.2% | 1,040,661 | -28.5% | 2.31% | -40.6% |
| Q1 2018 | $12,082,000 | +51.2% | 1,455,614 | +85.8% | 3.89% | +46.0% |
| Q4 2017 | $7,993,000 | +287.4% | 783,583 | +247.5% | 2.66% | +235.2% |
| Q3 2017 | $2,063,000 | – | 225,466 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 666,729 | $14,008,000 | 9.60% |
| DSC Advisors, L.P. | 907,358 | $17,157,000 | 8.33% |
| DAFNA Capital Management LLC | 63,400 | $1,332,000 | 1.32% |
| WALL STREET ASSOCIATES | 199,343 | $4,188,000 | 0.80% |
| Perceptive Advisors | 742,132 | $15,592,000 | 0.62% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 331,142 | $6,957,000 | 0.46% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 458,332 | $9,630,000 | 0.37% |
| EMERALD ADVISERS, LLC | 321,313 | $6,751,000 | 0.35% |
| Tourbillon Capital Partners, L.P. | 611,686 | $12,852,000 | 0.34% |
| DSC Advisors, L.P. | 31,240 | $656,000 | 0.32% |